Study Title: Phase 3 Study of Bomedemstat vs Best Available Therapy for 2L Essential Thrombocythemia
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Coltoff, Alexander, at coltoff@musc.edu.Study Coordinator, Baker, Hana, at bakerhan@musc.edu.Trial opened at the following institutions: Medical University of South Carolina